Clinical Trial

Monitoring the Response of Combination Ursodiol and Seladelpar Treatment

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to provide comprehensive insights into the therapeutic effects of combination treatment with ursodiol and seladelpar in PBC patients by assessing biochemical responses using biomarkers such as ALP and total bilirubin.
Trial Details
NCT Number NCT07122206
Lead Sponsor Methodist Health System
Conditions Primary Biliary Cholangitis
Enrollment 100 participants
Start Date 2025-08
Primary Completion 2027-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2025-08-14